Lake Street Private Wealth’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,787
Closed -$216K 299
2023
Q1
$216K Sell
2,787
-215
-7% -$16.6K 0.04% 258
2022
Q4
$233K Sell
3,002
-2,237
-43% -$165K 0.05% 245
2022
Q3
$352K Buy
5,239
+421
+9% +$31K 0.08% 198
2022
Q2
$370K Buy
+4,818
New +$376K 0.08% 203

Other funds holding PPH

Lake Street Private Wealth's PPH Position: Q2 2023 in Review

Lake Street Private Wealth sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 2,787 shares — an estimated $216K sold.

Lake Street Private Wealth first reported a position in PPH in Q2 2022 and held it in 4 quarters. The position peaked at $370K in Q2 2022. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

  • Lake Street Private Wealth reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
  • Lake Street Private Wealth sold 2,787 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $216K.
  • Lake Street Private Wealth first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 4 quarters.
  • Lake Street Private Wealth's VanEck Pharmaceutical ETF position peaked at $370K in Q2 2022.
  • 102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on Lake Street Private Wealth's 13F filing for Q2 2023, filed 18 Jul 2023.